{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:45:58Z","timestamp":1791042358446,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.metabol.2012.07.010","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T15:48:43Z","timestamp":1347551323000},"page":"90-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluating insulin secretagogues in a humanized mouse model with functional human islets"],"prefix":"10.1016","volume":"62","author":[{"given":"Jian","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Than","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bole","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid C.","family":"Rulifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.-H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Houze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.07.010_bb0005","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.07.010_bb0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/10.1210\/er.2006-0038","article-title":"beta-Cell failure in diabetes and preservation by clinical treatment","volume":"28","author":"Wajchenberg","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2012.07.010_bb0015","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","article-title":"Diabetes mellitus and the beta cell: the last ten years","volume":"148","author":"Ashcroft","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2012.07.010_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2004-1133","article-title":"beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis","volume":"90","author":"Ferrannini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.07.010_bb0025","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2337\/diabetes.55.04.06.db05-1100","article-title":"The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study","volume":"55","author":"Festa","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2012.07.010_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.55.1.7","article-title":"Pharmacological agents that directly modulate insulin secretion","volume":"55","author":"Doyle","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.metabol.2012.07.010_bb0035","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2165\/00003495-200464120-00006","article-title":"The role of sulphonylureas in the management of type 2 diabetes mellitus","volume":"64","author":"Rendell","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2012.07.010_bb0040","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-2004-826178","article-title":"GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes","volume":"36","author":"Ahren","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2012.07.010_bb0045","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2012.07.010_bb0050","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.2337\/dc11-s223","article-title":"Therapy in the early stage: incretins","volume":"34","author":"Cernea","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2012.07.010_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd2782","article-title":"Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes","volume":"8","author":"Ahren","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2012.07.010_bb0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543770903153878","article-title":"GPR119 agonists for the treatment of type 2 diabetes","volume":"19","author":"Jones","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.metabol.2012.07.010_bb0065","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/en.2006-1608","article-title":"A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release","volume":"148","author":"Chu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.010_bb0070","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/en.2007-0966","article-title":"A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release","volume":"149","author":"Chu","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.010_bb0075","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/db08-0130","article-title":"Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2012.07.010_bb0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1432-2277.2011.01332.x","article-title":"Stimulating beta cell replication and improving islet graft function by GPR119 agonists","volume":"24","author":"Gao","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.metabol.2012.07.010_bb0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2012.07.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2012.03.014","article-title":"GPR119 as a fat sensor","author":"Hansen","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2012.07.010_bb0100","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.transproceed.2011.10.021","article-title":"Stimulating beta-cell replication and improving islet graft function by AR231453, A gpr119 agonist","volume":"43","author":"Gao","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.metabol.2012.07.010_bb0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0026-0495(98)90027-0","article-title":"Nongenetic mouse models of non-insulin-dependent diabetes mellitus","volume":"47","author":"Luo","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.07.010_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/dmr.5610080302","article-title":"Animal models of non-insulin-dependent diabetes","volume":"8","author":"Shafrir","year":"1992","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.metabol.2012.07.010_bb0115","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.0510790103","article-title":"The unique cytoarchitecture of human pancreatic islets has implications for islet cell function","volume":"103","author":"Cabrera","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2012.07.010_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02581331","article-title":"Islet isolation assessment in man and large animals","volume":"27","author":"Ricordi","year":"1990","journal-title":"Acta Diabetol Lat"},{"key":"10.1016\/j.metabol.2012.07.010_bb0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1600-6143.2003.00351.x","article-title":"Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody","volume":"4","author":"Hering","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.metabol.2012.07.010_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/diab.47.2.159","article-title":"Glucagon-like peptides","volume":"47","author":"Drucker","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2012.07.010_bb0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/endo.142.2.7983","article-title":"Minireview: the glucagon-like peptides","volume":"142","author":"Drucker","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.010_bb0140","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1463-1326.2008.00853.x","article-title":"GLP-1: physiological effects and potential therapeutic applications","volume":"10","author":"Aaboe","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2012.07.010_bb0145","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1517\/14656566.8.15.2593","article-title":"Exenatide","volume":"8","author":"Barnett","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2012.07.010_bb0150","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1358\/dot.2011.47.11.1688575","article-title":"An update on exenatide, a novel therapeutic option for patients with type 2 diabetes","volume":"47","author":"Crasto","year":"2011","journal-title":"Drugs Today"},{"key":"10.1016\/j.metabol.2012.07.010_bb0155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.metabol.2004.05.009","article-title":"Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus","volume":"53","author":"Fonseca","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.07.010_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd2245","article-title":"Sitagliptin","volume":"6","author":"Drucker","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2012.07.010_bb0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00003495-200767040-00007","article-title":"Sitagliptin","volume":"67","author":"Lyseng-Williamson","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2012.07.010_bb0170","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/00003495-200363180-00001","article-title":"Metformin: new understandings, new uses","volume":"63","author":"Hundal","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2012.07.010_bb0175","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.07.010_bb0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2012.07.010_bb0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/14728222.11.5.661","article-title":"Fatty acid receptors as new therapeutic targets for diabetes","volume":"11","author":"Rayasam","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.metabol.2012.07.010_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.metabol.2008.10.005","article-title":"Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat","volume":"58","author":"Doshi","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.07.010_bb0195","doi-asserted-by":"crossref","first-page":"e27270","DOI":"10.1371\/journal.pone.0027270","article-title":"AMG 837: a novel GPR40\/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2012.07.010_bb0200","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2337\/diab.37.9.1163","article-title":"Diet-induced type II diabetes in C57BL\/6J mice","volume":"37","author":"Surwit","year":"1988","journal-title":"Diabetes"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2012.07.010_bb0205","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.2337\/diabetes.53.suppl_3.S215","article-title":"The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes","volume":"53","author":"Winzell","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2012.07.010_bb0210","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice","volume":"104","author":"Backhed","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2012.07.010_bb0215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1056-8719(00)00108-8","article-title":"HTS in the new millennium: the role of pharmacology and flexibility","volume":"44","author":"Landro","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.metabol.2012.07.010_bb0220","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2337\/diabetes.53.3.624","article-title":"Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects","volume":"53","author":"Deng","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2012.07.010_bb0225","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2012.07.010_bb0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181933261","article-title":"Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy","volume":"87","author":"Tian","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2012.07.010_bb0235","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/en.2010-0068","article-title":"Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor","volume":"151","author":"Tian","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.010_bb0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3727\/096368908786092775","article-title":"Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice","volume":"17","author":"Suarez-Pinzon","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.metabol.2012.07.010_bb0245","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1432-2277.2011.01275.x","article-title":"Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts","volume":"24","author":"Tian","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.metabol.2012.07.010_bb0250","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3727\/096368910X557263","article-title":"Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces beta-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice","volume":"20","author":"Suarez-Pinzon","year":"2011","journal-title":"Cell Transplant"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512002739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512002739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:58:29Z","timestamp":1758427109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512002739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0026049512002739"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.07.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating insulin secretagogues in a humanized mouse model with functional human islets","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}